Cours Apyx Medical Corp Nasdaq
Actions
US03837C1062
Equipement, fournitures et distribution médicale
CA 2024 * | 50,01 M 45,55 M | CA 2025 * | 54,67 M 49,8 M | Capitalisation | 55,43 M 50,49 M |
---|---|---|---|---|---|
Résultat net 2024 * | -26 M -23,68 M | Résultat net 2025 * | -24 M -21,86 M | VE / CA 2024 * | 1,11 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 1,01 x |
PER 2024 * |
-2,13
x | PER 2025 * |
-2,36
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 82,08% |
Dernier transcript sur Apyx Medical Corp
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15/12/17 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 15/03/11 |
Craig Swandal
BRD | Director/Board Member | 63 | 09/03/18 |
John Andres
BRD | Director/Board Member | 66 | 17/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
-6,76% | 180 Md | |
+3,27% | 112 Md | |
-3,74% | 68,53 Md | |
+5,21% | 51,97 Md | |
+5,57% | 44,08 Md | |
+5,62% | 42,23 Md | |
+24,45% | 32,43 Md | |
+16,72% | 26,39 Md | |
-3,75% | 24,97 Md |